Posts

Mid-October, some 500 tons of fake medicines were confiscated in international raids. They included ineffective potency-enhancing drugs, pain killers and dietary supplements as well as counterfeit cancer drugs. According to Interpol, 116 countries were involved in the operation and 850 suspects arrested. This again shows the importance of tamper-proof packaging. An EU Directive-compliant closure seal provides an effective solution.

Treatment by self-medication with autoinjectors: a growing trend. For patients, the ease and safety of handling are particularly important. For pharmaceutical manufacturers, the protection of patients against fake medicines and security of the supply chain are crucial. The EU FMD, besides serialization, requires tamper protection of secondary packaging, however without considering first-opening indication for injection devices. That is exactly what the NFC-Label for autoinjectors is offering.

In Europe, our Schreiner MediPharm business unit successfully premiered its new Booklet-Label with integrated closure seal and digital features at Pharmapack in Paris at the beginning of February. Now, the U.S. market launch is coming up at Interphex in New York in mid-March.

There’s a dark side dormant in all of us… Pharmapack visitors will be able to test their criminal skills at Schreiner MediPharm’s booth (M31) in Hall 4 this year. The challenge: Everyone will be invited to try to open Schreiner MediPharm’s closure seals for pharmaceutical packaging without their tampering attempts being detected. This special activity will take place in the light of EU Regulation 2016/161 supplementing the Falsified Medicine Directive, which all pharmaceutical manufacturers of